173 related articles for article (PubMed ID: 6264673)
1. Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71.
Schwarz H; Ihle JN; Wecker E; Fischinger PJ; Thiel HJ; Bolognesi DP; Schäfer W
Virology; 1981 Jun; 111(2):568-78. PubMed ID: 6264673
[No Abstract] [Full Text] [Related]
2. The GIX antigen of murine leukemia virus: an analysis with monoclonal antibodies.
Pierotti M; DeLeo AB; Pinter A; O'Donnell PV; Hämmerling U; Fleissner E
Virology; 1981 Jul; 112(2):450-60. PubMed ID: 6167060
[No Abstract] [Full Text] [Related]
3. Amplified expression of murine leukemia virus (MuLV)-coded antigens on thymocytes and leukemia cells of AKR mice after infection by dualtropic (MCF) MuLV.
O'Donnell PV; Nowinski RC; Stockert E
Virology; 1982 Jun; 119(2):450-64. PubMed ID: 6177096
[No Abstract] [Full Text] [Related]
4. Group-specific cytolytic antibody directed against the major glycoprotein (gp70) of murine leukemia viruses in serum of mice with dormant FLV infections.
Callahan RM; Marx PA; Wheelock EF
Virology; 1979 Aug; 97(1):55-67. PubMed ID: 224581
[No Abstract] [Full Text] [Related]
5. [Spontaneous leukemia of AKR mice. Successful passive immunization with goat antibodies against isolated glycoprotein gp71 of Friend leukemia virus].
Schwarz H; Thiel HJ; Schäfer W
Z Naturforsch C Biosci; 1977; 32(5-6):459-61. PubMed ID: 141818
[TBL] [Abstract][Full Text] [Related]
6. MCF-specific murine monoclonal antibodies made against AKR-247 MCF virus recognize a unique determinant associated with the gp70-p-15(E) complex.
Cloyd MW; Chesebro B; Portis JL; Weir M
J Virol; 1982 Mar; 41(3):1112-7. PubMed ID: 6178839
[TBL] [Abstract][Full Text] [Related]
7. Serological analysis of antigenic determinants on the env gene products of AKR dualtropic (MCF) murine leukemia viruses.
O'Donnell PV; Nowinski RC
Virology; 1980 Nov; 107(1):81-8. PubMed ID: 6160678
[No Abstract] [Full Text] [Related]
8. Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymus.
Weinhold KJ; Hüper G; Matthews TJ; Fischinger PJ; Ihle JN; Schwarz H; Thiel HJ; Schäfer W; Bolognesi DP
Virology; 1984 May; 135(1):105-17. PubMed ID: 6328742
[TBL] [Abstract][Full Text] [Related]
9. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus.
Lee JC; Ihle JN; Huebner R
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):343-7. PubMed ID: 189311
[TBL] [Abstract][Full Text] [Related]
10. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
Green WR; Nowinski RC; Henney CS
J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
[No Abstract] [Full Text] [Related]
11. The structural proteins of murine leukemia virus and the pathogenesis of necrotizing arteritis and glomerulonephritis in SL/Ni mice.
Yoshiki T; Hayasaka T; Fukatsu R; Shirai T; Itoh T; Ikeda H; Katagiri M
J Immunol; 1979 May; 122(5):1812-20. PubMed ID: 221579
[No Abstract] [Full Text] [Related]
12. Prevention of spontaneous leukemia in AKR mice by passive immunization and type specificity of this protection.
Fish DC; Gilden RV; Bare RM; Trimmer RM; Huebner RJ
J Natl Cancer Inst; 1979 Apr; 62(4):943-5. PubMed ID: 219284
[TBL] [Abstract][Full Text] [Related]
13. XVIII. Effective treatment of AKR leukemia with antibody to gp7 1 eliminates the neonatal burst of ecotropic AKR virus producing cells.
Fischinger PJ; Dunlop NM; Schwarz H; Ihle JN; Weinhold K; Bolognesi DP; Schafer W
Virology; 1982 May; 119(1):68-81. PubMed ID: 6280386
[No Abstract] [Full Text] [Related]
14. Role of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: a model for studies in human acquired immunodeficiency syndrome.
Thiel HJ; Schwarz H; Fischinger P; Bolognesi D; Schäfer W
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5893-7. PubMed ID: 3039513
[TBL] [Abstract][Full Text] [Related]
15. Lysis of retroviruses with monoclonal antibodies against viral envelope proteins.
Oroszlan S; Nowinski RC
Virology; 1980 Feb; 101(1):296-9. PubMed ID: 6243827
[No Abstract] [Full Text] [Related]
16. Natural immunity to endogenous oncornaviruses in mice.
Ihle JN; Hanna MG
Contemp Top Immunobiol; 1977; 6():169-74. PubMed ID: 194747
[No Abstract] [Full Text] [Related]
17. Autogenous immunity to endogenous RNA tumor virus: virion and virus-induced cell surface antigens.
Longstreth JD; Ihle JN; Hanna MG
Ann N Y Acad Sci; 1976; 276():343-57. PubMed ID: 68698
[No Abstract] [Full Text] [Related]
18. Antibodies to the envelope protein (gp70) of endogenous xenotropic and ecotropic leukemia viruses: induction by immunization with leukemia cells.
Boiocchi M; Nowinski RC
Virology; 1979 Jul; 96(1):281-5. PubMed ID: 88799
[No Abstract] [Full Text] [Related]
19. Inhibition of normal mouse lymphocyte mitogen responses by xenogeneic or allogeneic antibodies to the MuLV glycoprotein gp71.
Lee JC; Ihle JN
J Immunol; 1976 Sep; 117(3):1033-8. PubMed ID: 182879
[TBL] [Abstract][Full Text] [Related]
20. Genetic and viral factors influencing the development of spontaneous leukemia in AKR mice.
Nowinski RC; Brown M; Doyle T; Prentice RL
Virology; 1979 Jul; 96(1):186-204. PubMed ID: 223299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
